Chad Winters - Dec 4, 2023 Form 4/A Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Role
VP, Chief Accounting Officer
Signature
/s/ Luis Cantarero
Stock symbol
WST
Transactions as of
Dec 4, 2023
Transactions value $
-$229,069
Form type
4/A
Date filed
12/21/2023, 12:54 PM
Date Of Original Report
Dec 5, 2023
Previous filing
Dec 5, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WST Common Stock Options Exercise $65.4K +456 +30.69% $143.43 1.94K Dec 4, 2023 Direct F1
transaction WST Common Stock Sale -$354K -1.01K -44.38% $349.00 1.27K Dec 4, 2023 Direct F1
transaction WST Common Stock Options Exercise $59.1K +341 +17.56% $173.22 2.28K Dec 4, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WST Stock Options (Right to Buy) Options Exercise $0 -456 -100% $0.00* 0 Dec 4, 2023 Stock Options (Right to Buy) 456 $143.43 Direct F1
transaction WST Stock Options (Right to Buy) Options Exercise $0 -341 -17.83% $0.00 1.57K Dec 4, 2023 Stock Options (Right to Buy) 341 $173.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a revision to accurately reflect option exercises and sales that Chad Winters requested on December 1, 2023 that were completed on December 4, 2023 due to a record-keeping system outage.